| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |